The authors advocate pharmacoeconomic evaluation of new antihypertensive drugs before acceptance by formulary decision makers.
Arijit Ganguli, BS Pharm, MBA
Advertisement
Articles by Arijit Ganguli, BS Pharm, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
2
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
3
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
4
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
5